BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02484404-completion@plaintrial.com
DTSTAMP:20261027T211208Z
DTSTART;VALUE=DATE:20260701
SUMMARY:Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab A
 ntibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advan
 ced Solid Tumors and Advanced or Recurrent Ovarian\, Triple Negative Breas
 t\, Lung\, Prostate and Colorectal Can... — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02484404
URL:https://plaintrial.com/trial/NCT02484404
END:VEVENT
END:VCALENDAR